(Q43783004)

26 November 2017

title

Marker gene polymorphisms in hyperkinetic disorder--predictors of clinical response to treatment with methylphenidate? (English)

1 reference

26 November 2017

Seeger G

1

1 reference

26 November 2017

Schloss P

series ordinal

2

1 reference

26 November 2017

Schmidt MH

series ordinal

3

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

26 November 2017

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

26 November 2017

volume

313

1 reference

26 November 2017

issue

1-2

1 reference

26 November 2017

page(s)

45-48

1 reference

Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Fluoxetine for ADHD in a young child

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Normative data on revised Conners Parent and Teacher Rating Scales

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

An animal model of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Growth hormone and prolactin secretion in adults and hyperactive children: Relation to methylphenidate serum levels

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Serotonin Transporter and Seasonal Variation in Blood Serotonin in Families with Obsessive-Compulsive Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Allelic Variation of Human Serotonin Transporter Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Endocrine and behavioral responses to methylphenidate in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

A hypervariable segment in the human dopamine receptor D4 (DRD4) gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

1 reference

7 January 2021

Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

A children's global assessment scale (CGAS)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Dopamine genes and ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Effects of acute and chronic methylphenidate administration on beta-endorphin, growth hormone, prolactin and cortisol in children with attention deficit disorder and hyperactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902253-4

7 January 2021

10.1016/S0304-3940(01)02253-4

Identifiers

DOI

1 reference

26 November 2017

1 reference